We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Kooth Plc | LSE:KOO | London | Ordinary Share | GB00BMCZLK30 | ORD 5P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 4.00 | 2.76% | 149.00 | 39,694 | 14:17:37 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 145.00 | 153.00 | 149.00 | 145.00 | 145.00 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Spec Outpatient Facility,nec | 33.34M | -169k | -0.0046 | -323.91 | 52.9M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 14:21:24 | O | 13 | 152.20 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 15/4/2025 | 21:47 | ALNC |  EARNINGS AND TRADING: Everyman Media loss widens; Kooth back in profit |
| 15/4/2025 | 08:00 | ALNC | *Kooth expect growth in US market, securing contract wins with state.. |
| 15/4/2025 | 07:00 | UK RNS | Kooth PLC Full Year Results |
| 31/3/2025 | 13:00 | UK RNS | Kooth PLC Holding in Company |
| 28/2/2025 | 07:00 | UK RNS | Kooth PLC Block Listing Six Monthly Return |
| 13/2/2025 | 07:00 | UK RNS | Kooth PLC Transaction in Own Shares |
| 12/2/2025 | 07:00 | UK RNS | Kooth PLC Transaction in Own Shares |
| 11/2/2025 | 07:00 | UK RNS | Kooth PLC Transaction in Own Shares |
| 10/2/2025 | 07:00 | UK RNS | Kooth PLC Transaction in Own Shares |
| 07/2/2025 | 07:00 | UK RNS | Kooth PLC Transaction in Own Shares |
Kooth (KOO) Share Charts1 Year Kooth Chart |
|
1 Month Kooth Chart |
Intraday Kooth Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 19/4/2025 | 21:59 | Kooth-Looking for some healthy growth. | 237 |
| 04/7/2023 | 07:22 | Kooth | - |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 21/4/2025 09:20 by Kooth Daily Update Kooth Plc is listed in the Spec Outpatient Facility,nec sector of the London Stock Exchange with ticker KOO. The last closing price for Kooth was 145p.Kooth currently has 36,480,873 shares in issue. The market capitalisation of Kooth is £54,356,501. Kooth has a price to earnings ratio (PE ratio) of -323.91. This morning KOO shares opened at 145p |
Posted at 30/10/2024 13:45 by hatfullofsky On 30 October 2024, Timothy Barker (Chief Executive Officer) purchased 20,000 Ordinary Shares in Kooth at a price of 160p per Ordinary Share at a total value of £32,000. Following the transaction Timothy Barker has a total interest of 861,692 Ordinary Shares, representing 2.30% of the total voting rights.On 30 October 2024, Sanjay Jawa (Chief Financial Officer) purchased 20,000 Ordinary Shares in Kooth at a price of 160.5p per Ordinary Share at a total value of £32,100. Following the transaction Sanjay Jawa has a total interest of 373,981 Ordinary Shares, representing 1.02% of the total voting rights. |
Posted at 25/10/2024 10:19 by dave4545 Freefall watching it on L2 and always well offered too.Might be a trade but from what low price ? |
Posted at 24/10/2024 16:41 by hatfullofsky It's trading below the price on the California Contract announcement on 16/03/23 185p (so that's now in for free) and the £10m placing at 261pIt's now on an EV of £55m (inc £15m cash) |
Posted at 20/10/2024 10:42 by pireric KOO has basically become a 'woke' target in the US. Great timing from the secondary sellers to sell when they did. If Trump wins Presidency and the Republicans gain more ground, it has to be a net negative for Kooth in my view. In any case, I don't love how they're trying to sell mental health services in an equity structure as a high margin SaaS story (that's just the revenue model...).Eric |
Posted at 08/10/2024 17:03 by texaspete2 Sign of strength perhaps that the price hasn't touched 280p today, was hoping to add at this level |
Posted at 27/9/2024 08:46 by tightfist Interest may be related to an alarming FT article this morning: "John Burn-Murdoch today crunches the data to look at the worrying rise of young people on health-related benefits. In the UK, the share of 16 to 24-year-olds reporting a health problem that reduces their ability to carry out day-to-day activities has almost tripled since 2007, to 20 per cent. And the pattern is borne out in data showing a rise in disability claims linked to mental health in the west. |
Posted at 17/9/2024 07:40 by hatfullofsky Kooth Delivers Record Revenue and Profit in H1 2024Fantastic Results |
Posted at 04/7/2024 09:30 by hatfullofsky Kooth Plc KOO.L: Berenberg initiates coverage with buy rating; target price 590p |
Posted at 16/7/2023 10:45 by rimau1 Broker note from Liberum - consistent with my valuation assumptions posted last week.Koo, a front-runner in the personalised digital mental health sector, could offer a significant value proposition for investors, according to a recent note by UK brokerage firm Liberum. The company's shares, currently priced at 346p, are undervalued based on Liberum's price target of 457p. But the growth potential doesn't stop there. Liberum points to the potential for more US contracts and licensing opportunities, which could add a further 400p over time, effectively more than doubling the company's share price. The timing couldn't be better for Kooth, as it enters the fray in a world grappling with a mental health crisis. It's one of the few companies with a proven solution to address this, and it's already a market leader in the UK. Recently, the company managed to secure transformational contracts in the US, worth $180 million and indicating its scalability and potential for international expansion. The California deal is a prime example of this, which could potentially triple Kooth's revenue. As the company moves forward, key value drivers will include technology updates for the California contract, scaling up in Pennsylvania and California, and renewing the Pennsylvania contract. However, it should be noted that there is a high execution risk over the next twelve months. Liberum emphasises what the market might be overlooking. The breadth and scalability of Kooth's offerings are difficult to replicate, making it a unique player in the sector. Licensing will also enable Kooth to scale rapidly and with less risk. |
Posted at 04/7/2023 09:02 by timgaunt Great that they have confirmed this contract, but disappointed with the fundraising. They are raising at 10% below the current share price diluting shareholders more than necessary and providing a 10% bump for the directors and institutions who have been invited to participate. The directors have made circa 40k today. No small shareholders as per usual. They should have said 'not less than 300p'. I hope the institutions are tied in for a lengthy period. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
.png){kind=logo}
